Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationCost of RevenueEBIATLeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Receivables - NetShares Issued
Ratios

GeneDx Holdings (WGSWW) Shares Issued (2020 - 2025)

GeneDx Holdings has reported Shares Issued over the past 6 years, most recently at $45.7 million for Q4 2025.

  • Quarterly results put Shares Issued at $45.7 million for Q4 2025, up 11504.57% from a year ago — trailing twelve months through Dec 2025 was $46.7 million (up 11753.81% YoY), and the annual figure for FY2025 was $46.7 million, up 11753.81%.
  • Shares Issued for Q4 2025 was $45.7 million at GeneDx Holdings, up from -$280000.0 in the prior quarter.
  • Over the last five years, Shares Issued for WGSWW hit a ceiling of $442.7 million in Q3 2021 and a floor of -$143.0 million in Q4 2023.
  • Median Shares Issued over the past 5 years was $330000.0 (2023), compared with a mean of $28.7 million.
  • Biggest five-year swings in Shares Issued: plummeted 953.84% in 2021 and later soared 11504.57% in 2025.
  • GeneDx Holdings' Shares Issued stood at -$92.7 million in 2021, then soared by 313.26% to $197.7 million in 2022, then crashed by 172.35% to -$143.0 million in 2023, then skyrocketed by 100.28% to $394000.0 in 2024, then soared by 11504.57% to $45.7 million in 2025.
  • The last three reported values for Shares Issued were $45.7 million (Q4 2025), -$280000.0 (Q3 2025), and $527000.0 (Q2 2025) per Business Quant data.